|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||40.84 - 41.27|
|52-week range||40.84 - 41.27|
|Beta (5Y monthly)||1.32|
|PE ratio (TTM)||14.84|
|Earnings date||21 Feb 2022 - 25 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.
We provide five reasons, which make Halozyme (HALO) a good investment option in 2022.